Alcantara, Darlene I.
HRN: 19-26-52 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/01/2022
CEFUROXIME 500MG (TAB)
12/01/2022
12/08/2022
ORAL
500mg
Q12
S/P Repair Of 2nd Degree Perineal Laceration
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes